Background: This retrospective register study assessed overall survival (OS) and influential factors on OS in Swedish renal cell carcinoma (RCC) patients. Methods: Using three merged national health registers, Cox proportional-hazards analysis was conducted and, in three models, it was used to assess the impact of cytokine (interferon-a and tyrosine kinase inhibitor (TKI; sunitinib or sorafenib) treatment on OS in metastatic (m)RCC
Objective: Patients with clinical T1 renal cell carcinoma (cT1RCC) have risks for recurrence and red...
Background: T1a renal cell carcinoma (RCC) is typically considered a curable disease, irrespective o...
Purpose: Indications of kidney cancer outcome in lower-income countries are based on an incidence/mo...
Background: This retrospective register study assessed overall survival (OS) and influential factors...
AIM: To evaluate the implementation of targeted therapy on overall survival (OS) in a complete natio...
AbstractAimTo evaluate the implementation of targeted therapy on overall survival (OS) in a complete...
Global survival studies have shown favorable development in renal cell carcinoma (RCC) treatment but...
BACKGROUND: The most important prognostic factors for survival in patients with metastatic renal cel...
none7siThe aims of this study were to create a cohort of retrospectively collected renal cell carcin...
Methodology: Since the start in 2005 virtually all patients with newly diagnosed renal cell carcinom...
Background: Metastatic papillary renal cell carcinoma (mPRCC) is understudied. The disease is often ...
Copyright © 2015 Andreas Thorstenson et al. This is an open access article distributed under the Cre...
International audienceBACKGROUND:Patient characteristics and survival outcomes in randomized trials ...
Renal cell carcinoma (RCC), a common malignancy worldwide, affects 1200 new patients yearly in Swede...
BACKGROUND: Metastatic papillary renal cell carcinoma (mPRCC) is understudied. The disease is often ...
Objective: Patients with clinical T1 renal cell carcinoma (cT1RCC) have risks for recurrence and red...
Background: T1a renal cell carcinoma (RCC) is typically considered a curable disease, irrespective o...
Purpose: Indications of kidney cancer outcome in lower-income countries are based on an incidence/mo...
Background: This retrospective register study assessed overall survival (OS) and influential factors...
AIM: To evaluate the implementation of targeted therapy on overall survival (OS) in a complete natio...
AbstractAimTo evaluate the implementation of targeted therapy on overall survival (OS) in a complete...
Global survival studies have shown favorable development in renal cell carcinoma (RCC) treatment but...
BACKGROUND: The most important prognostic factors for survival in patients with metastatic renal cel...
none7siThe aims of this study were to create a cohort of retrospectively collected renal cell carcin...
Methodology: Since the start in 2005 virtually all patients with newly diagnosed renal cell carcinom...
Background: Metastatic papillary renal cell carcinoma (mPRCC) is understudied. The disease is often ...
Copyright © 2015 Andreas Thorstenson et al. This is an open access article distributed under the Cre...
International audienceBACKGROUND:Patient characteristics and survival outcomes in randomized trials ...
Renal cell carcinoma (RCC), a common malignancy worldwide, affects 1200 new patients yearly in Swede...
BACKGROUND: Metastatic papillary renal cell carcinoma (mPRCC) is understudied. The disease is often ...
Objective: Patients with clinical T1 renal cell carcinoma (cT1RCC) have risks for recurrence and red...
Background: T1a renal cell carcinoma (RCC) is typically considered a curable disease, irrespective o...
Purpose: Indications of kidney cancer outcome in lower-income countries are based on an incidence/mo...